Matinas BioPharma Holdings, Inc.(MTNB)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Matinas BioPharma Holdings, Inc. (MTNB) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. MTNB is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $3.2m in revenue and is scored on the micro-cap board instead. Top institutional holders of MTNB by reported 13-F value include RENAISSANCE TECHNOLOGIES, BlackRock, GEODE CAPITAL MANAGEMENT, based on the most recent SEC filings. MTNB trades on the NYSE exchange and files with the SEC under CIK 1582554. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MTNB daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Matinas BioPharma Holdings, Inc. directly from SEC EDGAR.

Net Income

$-1.3M

MTNB key financials by period

Matinas BioPharma Holdings, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202310-K$1.1M$-22.9M—
FY 202210-K$3.2M$-21.0M—
FY 202110-K/A$33.3K$-23.3M—
FY 202010-K/A$158.3K$-22.4M—
FY 201910-K/A$89.8K$-17.4M—
FY 201810-K$119.8K$-14.1M—

Institutions holding MTNB

Institutional investors reporting a position in Matinas BioPharma Holdings, Inc. on SEC Form 13F.
InstitutionSharesValueReported
RENAISSANCE TECHNOLOGIES71,040$43.5K2026-06-30
BlackRock50,262$30.8K2026-06-30
GEODE CAPITAL MANAGEMENT49,135$30.1K2026-06-30
VANGUARD CAPITAL MANAGEMENT40,110$24.5K2026-06-30
Holos Integrated Wealth32,480$20.2K2026-06-30
VANGUARD FIDUCIARY17,316$10.6K2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP16,093$9.8K2026-06-30
CITADEL ADVISORS15,465$9.5K2026-06-30
STATE STREET15,322$9.4K2026-06-30
Sargent Investment Group12,720$7.8K2026-06-30
SEC EDGAR: CIK 1582554 →
MTNB

Matinas BioPharma Holdings, Inc.

MTNB
NYSESmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $3.2M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-1.33M

EPS (Diluted)

Q2 2026
EDGAR

$-0.21

Top Institutional Holders

as of Q2 2026
$199.2K total
RENAISSANCE TECHNOLOGIES LLC
$43.5K+148.7%
BlackRock, Inc.
$30.8K+1.2%
GEODE CAPITAL MANAGEMENT, LLC
$30.1K-24.6%
VANGUARD CAPITAL MANAGEMENT LLC
$24.5K0.0%
Holos Integrated Wealth LLC
$20.2K0.0%
VANGUARD FIDUCIARY TRUST CO
$10.6K-5.3%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$9.8K+12.3%
CITADEL ADVISORS LLC
$9.5K-70.1%
STATE STREET CORP
$9.4K0.0%
Sargent Investment Group, LLC
$7.8K0.0%

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…